When to consider FDG-PET imaging in solitary pulmonary nodules

Clinical Pulmonary Medicine

Volumn 4, Issue 6, 1997, Pages 344-350

  Dewan, Naresh A ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

F 18 fluoro 2 deoxy D glucose; FDG; PET; Positron emission tomography; Solitary pulmonary nodules

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ASPIRATION BIOPSY; CANCER STAGING; COST CONTROL; DIAGNOSTIC ACCURACY; LUNG NODULE; MORBIDITY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; REVIEW; RISK BENEFIT ANALYSIS; THORACOTOMY; TREATMENT PLANNING;

EID: 0030734524     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199711000-00007     Document Type: Review

References (35)

1. Lillington GA. Management of solitary pulmonary nodules. Dis Mon 1991;37:271-318.
2. Stoller JD, Ahmad M, Rice TW. Solitary pulmonary nodule. Cleve Clin J Med 1988;55:68-74.
3. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47: 5-27.
4. Good CA, Wilson TW. Solitary pulmonary nodule. JAMA 1958;166:210-5.
5. Zerhouni EA, Stitik FP, Sigelman SS, Naidich DP, Sagel SS, Proto AV. CT of the pulmonary nodule: cooperative study. Radiology 1986; 160:319-27.
6. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasm. Cancer 1987;69:2682-9.
7. Wahl RL, Hutchins GD, Buchsbaum DJ, Liebert M, Grossman HB, Fisher S. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer 1991;67:1544-50.
8. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules - potential role in evaluation and management. Chest 1993;104:997-1002.
9. Patz EJ, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-90.
10. Scott WJ, Gobar LS, Terry JD, et al. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996;111:642-8.
11. Patz EJ, Lowe VJ, Goodman PC, Herndon J. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. Chest 1995;108:1617-21.
12. Frank A, Lefkowitz D, Jaeger S, et al. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int J Radiat Oncol Biol Phys 1995;32:1495-512.
13. Warburg O. The metabolism of tumors. 1st ed. New York: Richard R. Smith, 1931.
14. Monokhov NK, Niestadt EL, Shavlosii MM. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 1978;61:27-34.
15. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441-4.
16. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994;35:1771-6.
17. Coleman RE. Multicenter prospective study of FDG-PET in the evaluation of indeterminate solitary pulmonary nodules [abstract]. J Nucl Med 1995;36:34P.
18. Dewan NA, Reeb SK, Gupta NC, Scott WJ, Gobar LS. PET-FDG imaging and transthoracic needle lung biopsy in the evaluation of pulmonary lesions suspected to be malignant: a comparative risk-benefit analysis. Chest 1995;108:441-6.
19. Duhaylongsod FG, Lowe VJ, Patz EF, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;60:1348-52.
20. Bury T, Dowlati A, Paulus P, et al. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J 1996;9:410-4.
21. Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K. Likelihood of malignancy in a solitary pulmonary nodule. Comparison of Bayesian analysis and results of FDG-PET scan. Chest 1997;112:416-22.
22. Cummings SR, Lillington GA, Richard RJ. Estimating the probability of malignancy in solitary pulmonary nodules: a Bayesian approach. Am Rev Respir Dis 1986;134:449-52.
23. Swensen SJ, Brown LR, Colby TV, Weave AL. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995;194:393-8.
24. Swensen SJ, Jett JR, Payne HS, Viggiano RW, Pairolen PC, Trastee VG. An integrated approach to the evaluation of the solitary pulmonary nodule. Mayo Clin Proc 1990;65:173-86.
25. Dewan NA, Shehan CJ, Gobar LS, et al. Effect of PET-FDG imaging on management decisions in evaluation of lung lesions suspected to be malignant [abstract]. Chest 1995;108:150S.
26. Cummings SR, Lillington GA, Richard RJ. Managing solitary pulmonary nodules: the choice of strategy is a "close call." Am Rev Respir Dis 1986;134:455-60.
27. Dewan NA, Reeb SD, Gupta NC, et al. Decision analysis to compare the effectiveness and cost of PET-FDG imaging with various treatment strategies for solitary pulmonary nodules [abstract]. Chest 1994;106:88S.
28. Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J. Decision tree sensitivity analysis for cost effectiveness of FDG-PET in the staging of non-small-cell lung carcinoma. J Nucl Med 1996;37:1428-36.
29. Webb WR. Radiologic evaluation of the solitary pulmonary nodule. AJR Am J Roentgenol 1990;154:701-8.
30. Midthun DE, Swensen SJ, Jett JR. Clinical strategies for solitary pulmonary nodule. Annu Rev Med 1992;43:195-208.
31. Scott WJ, Gobar LS, Hauser LG, Sunderland JJ, Dewan NA, Sugimoto J. Detection of scalene lymph node metastasis from lung cancer. Chest 1995;107:1174-6.
32. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1996;60:1573-81.
33. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer - a PET study. J Nucl Med 1993;34:1-6.
34. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991;22: 623-8.
35. Donahue JK, Weichert RF, Ochsner JL. Bronchial adenoma. Ann Surg 1968;167:873-885.